ANTIBIOTIC RESISTANCE – WHERE ARE WE GOING?
Abstract: Introduction of antibiotics into clinical practice is considered as a turning point in medicine resulting in saving millions of lives and allowing for the development of new fields of medicine such as transplantology, neonatology, hematology and many others. From the very beginning, this success was accompanied by the emergence of antibiotic resistant strains with its continuous rise. Overuse and misuse of antibiotics in medicine, veterinary practice and animal and plant production are the main reasons the resistance has emerged. Presently, an increase in isolation of multidrug resistant (MDR), excessively resistant (XDR) and pandrug resistant (PDR) bacteria is being observed worldwide in the most common human etiologic bacterial agents. As examples of rapid evolution of resistance, S. aureus and Enterobacterales producing extended-spectrum beta-lactamases are presented. Some initiatives of WHO and EU aiming to tackle antibiotic resistance are also discussed.
